Dr. Reddy’s Postpones Generic Cancer Drug Release to 2030 in Patent Settlement with Eisai
Dr. Reddy’s Laboratories Inc., an Indian pharmaceutical company, has entered into an agreement to delay the market launch of its generic version of a cancer drug until 2030. This decision comes as a part of the settlement of a patent infringement lawsuit with Eisai Ltd., the original manufacturer of the drug. The case was presented…